Journal
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
Volume 23, Issue 4, Pages 635-643Publisher
SOC BRASILEIRA FARMACOGNOSIA
DOI: 10.1590/S0102-695X2013005000050
Keywords
Crotalus durissus terrificus; edematogenic effect; myotoxic activity; seaweed; secretory phospholipase A2; sulfated polysaccharides
Categories
Funding
- Research Foundation of the State of Sao Paulo (FAPESP) [2011/06704-4, 2011/14241-4]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/14241-4] Funding Source: FAPESP
Ask authors/readers for more resources
Sulfated polysaccharides derived from seaweed have shown great potential for use in the development of new drugs. In this study, we observed that a low-molecular-weight sulfated polysaccharide from Caulerpa racemosa, termed CrSP, could interact with secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus terrificus venom. When native sPLA2 (14 kDa) was incubated with CrSP, they formed a molecular complex (sPLA2: CrSP) with a molecular mass of 32 kDa, approximately. Size exclusion chromatography experiments suggested that CrSP formed a stable complex with sPLA2. We belived that sPLA2 and SPCr are involved an ionic interaction between negatively charged CrSP and the positively charged basic amino acid residues of sPLA2, because this interaction induced significant changes in sPLA2 enzymatic and pharmacological activities. CrSP caused a significant increase in sPLA2 enzymatic and bactericidal activity and increased its edematogenic effect. A pharmacological assay showed that the myotoxic activity of sPLA2: CrSP is unrelated to its enzymatic activity and that sPLA2: CrSP may have a practical application as a natural antibacterial agent for use in humans and commercially raised animals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available